
netupitant-palonosetron oral brand names and other generic formulations include:
Akynzeo Oral
guanfacine oral brand names and other generic formulations include:
Intuniv ER Oral, Tenex Oral
netupitant-palonosetron oral and guanfacine oral
netupitant-palonosetron oral will increase the level or effect of guanfacine oral by altering drug metabolism. Blood levels of guanfacine may increase. The dose of extended release guanfacine should be reduced by half.
netupitant-palonosetron oral and guanfacine oral
netupitant-palonosetron oral will increase the level or effect of guanfacine oral by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Strong or moderate CYP3A4 inhibitors significantly increase guanfacine plasma concentrations. FDA-approved labeling for extended-release (ER) guanfacine recommends that, if coadministered, the guanfacine dosage should be decreased to half of the recommended dose. Specific recommendations for immediate-release (IR) guanfacine are not available.
Check for more interactions with the Drug Interaction Checker
Drug Interaction Categories
Contraindicated
Never use this combination of drugs because of high risk for dangerous interaction
Serious
Potential for serious interaction; regular monitoring by your doctor required or alternate medication may be needed
Significant
Potential for significant interaction (monitoring by your doctor is likely required)
Minor
Interaction is unlikely, minor, or nonsignificant